Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal typeJean-Marie Michot, Renaud Mazeron, Alina Danu, et al.The Lancet. Haematology|December 22, 2015
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 studyJehan Dupuis, Franck Morschhauser, Hervé Ghesquières, et al.Blood|March 9, 2017
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphomaCharles Herbaux, Jordan Gauthier, Pauline Brice, et al.Oncoimmunology|January 12, 2023
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignanciesCamille Bigenwald, Yacine Haddad, Cassandra Thelemaque, et al.Blood Advances|April 12, 2021
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNALieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, et al.Cancer Medicine|February 24, 2018
Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studiesAurélie Cabannes-Hamy, Frederic Peyrade, Fabrice Jardin, et al.Bulletin Du Cancer|January 1, 2018
[Hodgkin lymphoma: Current and future therapeutic strategies]Anthony Turpin, Jean-Marie Michot, Emmanuelle Kempf, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)Isabelle Demeestere, Judith Racape, Julie Dechene, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin LymphomaMassimo Federico, Catherine Fortpied, Yana Stepanishyna, et al.Investigational New Drugs|June 10, 2017
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trialsJean-Marie Michot, Lina Benajiba, Laura Faivre, et al.Pageof 5